Response to Cabantchik and Hershko commentary "Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation"

Am J Hematol. 2022 Feb 1;97(2):E58-E59. doi: 10.1002/ajh.26419. Epub 2021 Dec 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Dietary Supplements
  • Humans
  • Iron Overload* / drug therapy
  • Iron Overload* / etiology
  • Iron*

Substances

  • Iron